Overexpression of ADAM9 has been found in thyroid cancer and other cancers, including breast cancer, hepatocellular carcinoma, pancreatic cancer, prostate cancer, and melanoma [35,40,42–47]. Here, ADAM9 is linked to hepatocellular carcinoma.